CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR Surgical has secured US Food and Drug Administration (FDA) clearance ...

PHOENIX, April 2, 2025 /PRNewswire/ -- Trinity Capital Inc. (TRIN) (NASDAQ: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of up to $68.75 million in growth ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

CMR Surgical receives CE Mark for use of Versius in paediatric surgery Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January 2026, ...

The U.S. FDA granted Momentis Surgical Ltd. 510(k) clearance for its Anovo robotic surgical platform for use in single site, abdominal access ventral hernia repairs. The U.S. regulatory agency also ...